Lv52
1360 积分 2021-03-29 加入
Unlocking the potential of bispecific ADCs for targeted cancer therapy
1天前
已完结
Molecular basis of PD-1 blockade by dostarlimab, the FDA-approved antibody for cancer immunotherapy
18天前
已完结
Nonoperative Management of Mismatch Repair–Deficient Tumors
18天前
已完结
CD19 CAR T-Cell Therapy in Multidrug-Resistant Ulcerative Colitis
20天前
已完结
Characterization of Anti-CD3 Antibodies in Clinically Available Bispecific T Cell Engagers
20天前
已完结
Immunogenicity risk assessment and mitigation for engineered antibody and protein therapeutics
21天前
已完结
Role Of Artificial Intelligence In Cancer Drug Discovery And Development
22天前
已完结
Combining CD40 agonist mitazalimab with mFOLFIRINOX in previously untreated metastatic pancreatic ductal adenocarcinoma (OPTIMIZE-1): a single-arm, multicentre phase 1b/2 study
28天前
已完结
Concentration of IgG1 and IgG2a allotypes in serum of nude and normal allotype-congenic mice
1个月前
已完结
Regulation of murine IgE production in SJA/9 and nude mice. Potentiation of IgE production by recombinant interleukin 4
1个月前
已完结
皖公网安备34019202002308
